
|Articles|May 1, 2002
Supplements and Featured Publications
- Cost and Utilization Analysis for Rheumatoid Arthritis Treatments: An Update for Managed Care
- Volume 8
- Issue 7 Suppl
Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care Population
Advertisement
Articles in this issue
over 23 years ago
Participating FacultyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
In Vivo CAR T Takes Center Stage, With Results Shared for 4 MRD-Negative Patients
2
Price Transparency With Gaps: Assessing the Completeness of Payer Transparency in Coverage Data
3
Camizestrant-Related Photopsia Mostly Mild, Nondisabling in Patients With Advanced Breast Cancer: Adam Brufsky, MD, PhD
4
T-DXd Delivers Strong Breast Cancer Outcomes Across Groups
5














































